Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2012, Article ID 276803, 4 pages
http://dx.doi.org/10.1155/2012/276803
Review Article

Glycogen Synthase Kinase 3: A Point of Integration in Alzheimer's Disease and a Therapeutic Target?

1Department of Psychiatry, Douglas Hospital Research Center, McGill University, Montreal, QC, Canada H4H 1R3
2UTSA Neurosciences Institute and Department of Biology, College of Sciences, The University of Texas at San Antonio, San Antonio, TX, USA
3Department of Pathology, Case Western Reserve University, Cleveland, OH, USA
4Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal
5Faculty of Medicine, Institute of Physiology, University of Coimbra, Coimbra, Portugal

Received 7 February 2012; Revised 20 April 2012; Accepted 3 May 2012

Academic Editor: Francesco Panza

Copyright © 2012 Siddhartha Mondragón-Rodríguez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [15 citations]

The following is the list of published articles that have cited the current article.

  • Jillian L. Shaw, and Karen T. Chang, “Nebula/DSCR1 Upregulation Delays Neurodegeneration and Protects against APP-Induced Axonal Transport Defects by Restoring Calcineurin and GSK-3 beta Signaling,” Plos Genetics, vol. 9, no. 9, 2013. View at Publisher · View at Google Scholar
  • Bo Song, Qiang Ao, Ying Niu, Qin Shen, Huancong Zuo, Xiufang Zhang, and Yandao Gong, “Amyloid beta-peptide worsens cognitive impairment following cerebral ischemia-reperfusion injury,” Neural Regeneration Research, vol. 8, no. 26, pp. 2449–2457, 2013. View at Publisher · View at Google Scholar
  • Susan A. Farr, Jessica L. Ripley, Rukhsana Sultana, Zhaoshu Zhang, Michael L. Niehoff, Thomas L. Platt, M. Paul Murphy, John E. Morley, Vijaya Kumar, and D. Allan Butterfield, “Antisense Oligonucleotide Against GSK-3β in Brain of SAMP8 Mice Improves Learning and Memory and Decreases Oxidative Stress: Involvement of Transcription Factor Nrf2 and Implications for Alzheimer Disease,” Free Radical Biology and Medicine, 2013. View at Publisher · View at Google Scholar
  • Siddhartha Mondragón-Rodríguez, George Perry, Xiongwei Zhu, Paula I. Moreira, Mariana C. Acevedo-Aquino, and Sylvain Williams, “Phosphorylation of Tau Protein as the Link between Oxidative Stress, Mitochondrial Dysfunction, and Connectivity Failure: Implications for Alzheimer’s Disease,” Oxidative Medicine and Cellular Longevity, vol. 2013, pp. 1–6, 2013. View at Publisher · View at Google Scholar
  • Wolfgang Froestl, Andreas Muhs, and Andrea Pfeifer, “Cognitive enhancers (nootropics). Part 2: Drugs interacting with enzymes,” Journal of Alzheimer's Disease, vol. 33, no. 3, pp. 547–658, 2013. View at Publisher · View at Google Scholar
  • Ashok Kumar Datusalia, and Shyam Sunder Sharma, “Amelioration of Diabetes-induced Cognitive Deficits by GSK-3 beta Inhibition is Attributed to Modulation of Neurotransmitters and Neuroinflammation,” Molecular Neurobiology, vol. 50, no. 2, pp. 390–405, 2014. View at Publisher · View at Google Scholar
  • Wolfgang Froestl, Andreas Muhs, and Andrea Pfeifer, “Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes. Update 2014,” Journal of Alzheimers Disease, vol. 42, no. 1, pp. 1–68, 2014. View at Publisher · View at Google Scholar
  • Pierfausto Senecipp. 643–715, 2015. View at Publisher · View at Google Scholar
  • Alison Callahan, Juan Jose Cifuentes, and Michel Dumontier, “An evidence-based approach to identify aging-related genes in Caenorhabditis elegans,” Bmc Bioinformatics, vol. 16, 2015. View at Publisher · View at Google Scholar
  • Xianjuan Kou, Jie Li, Jing Bian, Yi Yang, Xiaoqi Yang, Jingjing Fan, Shaohui Jia, and Ning Chen, “Ampelopsin attenuates 6-OHDA-induced neurotoxicity by regulating GSK-3β/NRF2/ARE signalling,” Journal of Functional Foods, vol. 19, pp. 765–774, 2015. View at Publisher · View at Google Scholar
  • Pierfausto Senecipp. 1–241, 2015. View at Publisher · View at Google Scholar
  • Pierfausto Seneci, “Chemical Modulators of Protein Misfolding, Neurodegeneration and Tau,” Chemical Modulators of Protein Misfolding and Neurodegenerative Disease, pp. 1–23, 2015. View at Publisher · View at Google Scholar
  • Giulia Sita, Roberto Rimondini, Patrizia Hrelia, Fabiana Morroni, and Andrea Tarozzi, “Early effects of Aβ1-42 oligomers injection in mice: Involvement of PI3K/Akt/GSK3 and MAPK/ERK1/2 pathways,” Behavioural Brain Research, vol. 314, pp. 106–115, 2016. View at Publisher · View at Google Scholar
  • J. Alex Grizzell, Sagar Patel, George E. Barreto, and Valentina Echeverria, “Cotinine improves visual recognition memory and decreases cortical Tau phosphorylation in the Tg6799 mice,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 78, pp. 75–81, 2017. View at Publisher · View at Google Scholar
  • Siddhartha Mondragón-Rodríguez, George Perry, Fernando Peña-Ortega, and Sylvain Williams, “Tau, amyloid beta and deep brain stimulation: Aiming to restore cognitive deficit in alzheimer’s disease,” Current Alzheimer Research, vol. 14, no. 1, pp. 40–46, 2017. View at Publisher · View at Google Scholar